The nation’s infant mortality rate is falling. Some experts think one reason may be a vaccination campaign against RSV.

Here's what RSV is, why it especially impacts the youngest and oldest members of society and how it is usually treated.

Most infants hospitalised for RSV-related infections need oxygen support and critical care despite nirsevimab use, with ...

Far fewer babies had severe cases of the respiratory illness RSV, in a winter in which a new monoclonal and vaccine became ...

A Spanish study found that nirsevimab prophylaxis significantly reduced infant hospitalizations, ICU admissions, and severe ...

The CPS-Ped may be an efficient outcome metric for monitoring disease severity and clinical improvement over time among infants with RSV-related critical illness.

In a recent study of a population of infants, published online May 6 in Pediatrics, 72% of infants were found to be immunized ...

The overall uptake of RSV vaccine is low during its first season in those aged 60 years or older in the United States. The ...

For a broader group of infants—0 to 7 months old—RSV-NET showed a 43 percent drop in hospitalizations in the 2024–2025 RSV season, and NVSN saw a 28 percent drop. Again, when Houston was excluded from ...

CDC's RSV vaccine recommendations from Pfizer and GSK face review by HHS advisor William "Reyn" Archer III. Read more here.

ACIP is recommending that adults aged 50 to 59 years who are at increased risk for severe RSV disease receive a single dose of an RSV vaccine.

During the first respiratory syncytial virus (RSV) season in which a maternal vaccine and a monoclonal antibody for infants ...